|
KDM5A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.123700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.018300E-02 |
| Normal-vs-Stage2 |
5.587800E-02 |
| Normal-vs-Stage3 |
2.042400E-03 |
| Normal-vs-Stage4 |
2.018900E-03 |
| Stage1-vs-Stage2 |
6.590800E-01 |
| Stage1-vs-Stage3 |
8.303600E-02 |
| Stage1-vs-Stage4 |
1.038580E-01 |
| Stage2-vs-Stage3 |
4.463600E-01 |
| Stage2-vs-Stage4 |
4.228400E-01 |
| Stage3-vs-Stage4 |
9.352600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.338800E-03 |
| Normal-vs-AfricanAmerican |
1.639060E-04 |
| Normal-vs-Asian |
5.385400E-01 |
| Caucasian-vs-AfricanAmerican |
3.043600E-02 |
| Caucasian-vs-Asian |
1.492230E-01 |
| AfricanAmerican-vs-Asian |
3.570300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.104300E-03 |
| Normal-vs-Female |
1.691680E-02 |
| Male-vs-Female |
6.246600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.500200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.779900E-02 |
| Normal-vs-Age(61-80Yrs) |
2.679100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.620100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.906000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.065000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.269800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.407160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.087700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.980650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.655200E-01 |
| Normal-vs-Grade 2 |
7.048200E-02 |
| Normal-vs-Grade 3 |
1.199080E-03 |
| Normal-vs-Grade 4 |
3.774600E-04 |
| Grade 1-vs-Grade 2 |
3.019000E-01 |
| Grade 1-vs-Grade 3 |
6.573700E-02 |
| Grade 1-vs-Grade 4 |
3.211700E-02 |
| Grade 2-vs-Grade 3 |
3.430300E-02 |
| Grade 2-vs-Grade 4 |
1.521910E-02 |
| Grade 3-vs-Grade 4 |
3.423600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.855010E-01 |
| Normal-vs-ccB subtype |
6.958900E-03 |
| ccA subtype-vs-ccB subtype |
9.715900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.804270E-02 |
| Normal-vs-N1 |
5.526400E-01 |
| N0-vs-N1 |
7.923600E-01 |
|
|
